Dunhill Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.5K Sell
556
-3
-0.5% -$242 0.01% 357
2026
Q1
$48.5K Sell
559
-1
-0.2% -$96 0.01% 318
2025
Q4
$53.8K Sell
560
-148
-21% -$14.4K 0.01% 263
2025
Q3
$67.4K Sell
708
-4
-0.6% -$368 0.02% 225
2025
Q2
$62.1K Sell
712
-135
-16% -$11.4K 0.02% 218
2025
Q1
$76.1K Buy
847
+124
+17% +$11.1K 0.03% 157
2024
Q4
$57.7K Sell
723
-127
-15% -$11K 0.03% 172
2024
Q3
$76.6K Buy
850
+140
+20% +$11.8K 0.04% 135
2024
Q2
$55.8K Buy
710
+230
+48% +$18.9K 0.03% 139
2024
Q1
$41.8K Sell
480
-6
-1% -$512 0.03% 124
2023
Q4
$40.1K Sell
486
-880
-64% -$67.1K 0.04% 111
2023
Q3
$104K Buy
1,366
+46
+3% +$3.85K 0.07% 73
2023
Q2
$111K Buy
+1,320
New +$114K 0.07% 84

Other funds holding MDT

Dunhill Financial's MDT Position: Q2 2026 in Review

Dunhill Financial reduced its Medtronic (MDT) stake by 0.54% in Q2 2026, selling an estimated $242 and leaving 556 shares worth $43.5K. The position accounts for 0.01% of the portfolio, ranked #357.

Dunhill Financial first reported a position in MDT in Q2 2023 and has held it in 13 quarters since. The position peaked at $111K in Q2 2023. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Dunhill Financial held 556 shares of Medtronic worth $43.5K as of Q2 2026.
  • Dunhill Financial sold 3 Medtronic shares in Q2 2026, an estimated $242.
  • Medtronic made up 0.01% of Dunhill Financial's portfolio in Q2 2026, its #357 holding.
  • Dunhill Financial first reported a position in Medtronic in Q2 2023 and has held it in 13 quarters since.
  • Dunhill Financial's Medtronic position peaked at $111K in Q2 2023.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.